Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiromu Konno is active.

Publication


Featured researches published by Hiromu Konno.


Neurosurgery | 2003

Transcranial Regional Cerebral Oxygen Saturation Monitoring during Carotid Endarterectomy as a Predictor of Postoperative Hyperperfusion

Kuniaki Ogasawara; Hiromu Konno; Hirotsugu Yukawa; Hidehiko Endo; Takashi Inoue; Akira Ogawa

OBJECTIVEHyperperfusion syndrome is a rare but potentially devastating complication that can occur after carotid endarterectomy (CEA). The purpose of this study was to determine whether intraoperative transcranial regional cerebral oxygen saturation (rSO2) monitoring via near-infrared spectroscopy could be reliably used to identify patients at risk for post-CEA hyperperfusion. METHODSrSO2 was intraoperatively monitored for 50 patients undergoing CEA for treatment of ipsilateral internal carotid artery stenosis (≥70%). Cerebral blood flow (CBF) was also assessed, with single-photon emission computed tomography, before and immediately after CEA. RESULTSPost-CEA hyperperfusion (CBF increase of ≥100%, compared with preoperative values) was observed for six patients. A significant linear correlation was observed between the rSO2 increases immediately after declamping of the internal carotid artery and the CBF increases immediately after CEA (r2 = 0.247, P = 0.0002). The sensitivity and specificity of the rSO2 increases for detection of post-CEA hyperperfusion were 100 and 86.4%, respectively, with a cutoff point of 5%. A strong linear correlation was observed between the rSO2 increases at the end of the procedure and the CBF increases immediately after CEA (r2 = 0.822, P < 0.0001). Both the sensitivity and the specificity of the rSO2 increases for detection of post-CEA hyperperfusion were 100% with a cutoff point of 10%. Hyperperfusion syndrome developed for one patient with post-CEA hyperperfusion, but intracerebral hemorrhage did not occur. CONCLUSIONIntraoperative rSO2 monitoring can reliably identify patients at risk for hyperperfusion after CEA.


Journal of Cerebral Blood Flow and Metabolism | 2000

Prediction of acute embolic stroke outcome after local intraarterial thrombolysis : Value of pretreatment and posttreatment 99mTc-ethyl cysteinate dimer single photon emission computed tomography

Kuniaki Ogasawara; Akira Ogawa; Mamoru Doi; Hiromu Konno; Michiyasu Suzuki; Takashi Yoshimoto

The aim of this study was to investigate the efficacy of pre-and posttreatment 99mTc-ethyl cysteinate dimer (99mTc-ECD) single photon emission computed tomography (SPECT) for predicting the ischemic outcome of embolic middle cerebral artery occlusion after treatment with local intraarterial thrombolysis. The authors examined 28 patients with a moderately ischemic area (ratio of affected regional activity to cerebellar activity (A/C ratio) of 0.4 to 0.7) determined using pretreatment SPECT, and with complete recanalization within 6 hours. Posttreatment dynamic and static SPECT studies were performed immediately after thrombolysis. The extent of the affected area outlined on pretreatment SPECT was used for the posttreatment SPECT images, and A/C ratios were calculated. The relative retention ratio of 99mTc-ECD in the affected area was also analyzed using posttreatment dynamic SPECT. Fourteen patients either without infarction or with small subcortical and basal ganglial infarction, 11 patients with medium or large cortical infarction, and 3 patients with hemorrhage were identified by follow-up computed tomography. Ischemic outcome correlated with the relative retention ratio of 99mTc-ECD more closely than either the pre-or posttreatment A/C ratios. In particular, a threshold value for the development of hemorrhage was distinct only in the relative retention ratio of 99mTc-ECD. Pretreatment 99mTc-ECD SPECT did not always predict the occurrence of hemorrhagic transformation, whereas dynamic 99mTc-ECD SPECT performed immediately after thrombolysis allowed clear identification of patients at risk for hemorrhagic transformation.


Journal of Neurosurgery | 2009

Clinical and angiographic long-term outcomes of vertebral artery–subclavian artery transposition to treat symptomatic stenosis of vertebral artery origin

Shunsuke Kakino; Kuniaki Ogasawara; Yoshitaka Kubo; Hiroshi Kashimura; Hiromu Konno; Atsushi Sugawara; Masakazu Kobayashi; Makoto Sasaki; Akira Ogawa

OBJECT Although angioplasty and stent placement for vertebral artery (VA)-origin stenosis have been performed using endovascular techniques, a high likelihood of restenosis has been observed in the long term. Therefore, the authors assessed the long-term clinical and angiographic outcomes in patients after VA-subclavian artery (SA) transposition. METHODS Thirty-six patients (31 men, 5 women; mean age 64.3 years, range 46-76 years) underwent clinical evaluation (modified Rankin Scale [mRS]) and cervical angiographic evaluation preoperatively and within 1 month of and 6 months after VA-SA transposition undertaken to treat symptomatic stenosis of VA origin. RESULTS Postoperative neurological deficits due to intraoperative brain ischemia did not occur, and MR imaging demonstrated no new postoperative ischemic lesions in any of the patients. One patient died of acute myocardial infarction 2 months after surgery and another developed a left thalamic hemorrhage (mRS score of 5) at 42 months postsurgery. None of the remaining 34 patients experienced further ischemic events, and the mRS score in all of these patients remained unchanged during a mean follow-up period of 54 months. The degree of VA-origin stenosis (preoperative mean 84%) was reduced to < or = 30% after surgery (mean 2%). Long-term follow-up angiography in 29 patients (81%) revealed the absence of restenosis, defined as > 50% luminal narrowing, in all of them. CONCLUSIONS The clinical and angiographic long-term outcomes demonstrated here suggest that VA-SA transposition will be useful in patients with symptomatic stenosis of VA origin.


Clinical Nuclear Medicine | 2002

Very early and standard Tc-99m ethyl cysteinate dimer SPECT imaging in a patient with reperfusion hyperemia after acute cerebral embolism.

Kuniaki Ogasawara; Hiromu Konno; Shigeru Yasuda; Hirotsugu Yukawa; Akira Ogawa

&NA; It has been reported that Tc‐99m ethyl cysteinate dimer (ECD) SPECT imaging may not show reperfusion hyperemia in patients with subacute stroke. The authors describe a patient with embolic middle cerebral artery occlusion who was examined using xenon‐133 and dynamic and standard Tc‐99m ECD SPECT immediately after early recanalization. Standard Tc‐99m ECD SPECT images revealed hypoactivity in the ipsilateral middle cerebral artery territory. In contrast, the dynamic Tc‐99m ECD SPECT images from the first scan (very early images acquired 36 seconds after injection) showed hyperactivity in the same region and provided imaging contrast comparable to what would be obtained with xenon‐133 tomography. Hemorrhagic transformation later developed in this region. These results indicate that images from very early dynamic Tc‐99m ECD SPECT of areas with irreversible changes produced by acute stroke can reveal reflow hyperemia that standard Tc‐99m ECD SPECT images fail to show.


Journal of Neurosurgery | 2003

Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning

Kuniaki Ogasawara; Hirotsugu Yukawa; Masakazu Kobayashi; Chiaki Mikami; Hiromu Konno; Kazunori Terasaki; Takashi Inoue; Akira Ogawa


Journal of Neurosurgery | 2002

Quantification of susceptibility artifacts produced on high-field magnetic resonance images by various biomaterials used for neurosurgical implants. Technical note.

Hideki Matsuura; Takashi Inoue; Hiromu Konno; Makoto Sasaki; Kuniaki Ogasawara; Akira Ogawa


Neurologia Medico-chirurgica | 2005

Quantitative Analysis of Magnetic Resonance Imaging Susceptibility Artifacts Caused by Neurosurgical Biomaterials : Comparison of 0.5, 1.5, and 3.0 Tesla Magnetic Fields

Hideki Matsuura; Takashi Inoue; Kuniaki Ogasawara; Makoto Sasaki; Hiromu Konno; Yasutaka Kuzu; Hideaki Nishimoto; Akira Ogawa


American Journal of Neuroradiology | 2001

Brain Single-photon Emission CT Studies Using 99mTc-HMPAO and 99mTc-ECD Early after Recanalization by Local Intraarterial Thrombolysis in Patients with Acute Embolic Middle Cerebral Artery Occlusion

Kuniaki Ogasawara; Akira Ogawa; Masayuki Ezura; Hiromu Konno; Michiyasu Suzuki; Takashi Yoshimoto


The Journal of Nuclear Medicine | 2001

Dynamic and Static 99mTc-ECD SPECT Imaging of Subacute Cerebral Infarction: Comparison with 133Xe SPECT

Kuniaki Ogasawara; Akira Ogawa; Masayuki Ezura; Hiromu Konno; Mamoru Doi; Kiyoshi Kuroda; Takashi Yoshimoto


The Journal of Nuclear Medicine | 2000

Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction

Kuniaki Ogasawara; Akira Ogawa; Keiji Koshu; Hiromu Konno; Michiyasu Suzuki; Takashi Yoshimoto

Collaboration


Dive into the Hiromu Konno's collaboration.

Top Co-Authors

Avatar

Akira Ogawa

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takashi Inoue

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Makoto Sasaki

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mamoru Doi

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge